- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02811887
SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy (SMILE)
A Randomized, Pragmatic, Outcome-assessor-blinded Study of an SMS-message-based Lifestyle Intervention in Patients With Decompensated Liver Cirrhosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Physical exercise and other interventions focused on lifestyle factors have not only the potential to increase physical functioning and capacity, but also to affect fundamental aspects of disease, increase quality of life, and may even increase survival in patients with liver cirrhosis.
Instruction and advice about a healthy lifestyle and physical activity are attractive as it limits time spent on supervised rehabilitation at an outpatient clinic. Further, self-management can be attractive to society as it can conserve health care resources. However, instructions and advice can only be effective if the patients adhere to them, and there is a need for initiatives that enhance the motivation to follow the advice and change undesirable behaviours.
Mobile phone short-message service (SMS) messages are increasingly used to deliver interventions and enhance healthy behaviour. The technology is simple, cost-effective, can be automated, and can reach any mobile phone owner. In a recent systematic review, SMS-messages have been shown effective in a broad range of healthy behaviours, which was also highlighted in a randomized trial showing positive effects of lifestyle-focused SMS-messages on cardiovascular risk factors in patients with coronary heart disease. An SMS-message-based lifestyle intervention therefore seems like a feasible and effective means of enhancing motivation to follow advice about healthy lifestyle and physical activity among patients with liver cirrhosis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2400
- Bispebjerg Hospital, Department of Physical and Occupational Therapy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult, i.e. age 18 years or above.
- Is attending the liver cirrhosis rehabilitation clinic at Bispebjerg hospital; i.e., has alcohol-induced liver cirrhosis or hepatorenal syndrome and has at least once experienced severe decompensation in the form of hepatic encephalopathy or variceal haemorrhage.
- Has attended at least 50% of the scheduled sessions in the 12 week run-in physical exercise program
- Is the owner of a mobile phone capable of receiving SMS-messages
- Has signed informed consent
- Reads and speaks Danish
Exclusion Criteria:
1. Any condition that in the opinion of the investigator puts an otherwise eligible participant at increased risk by participation or otherwise make the person unfit for participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Usual care
12 weeks of supervised physical exercise followed by usual care in the outpatient liver cirrhosis rehabilitation clinic
|
A 12 week supervised and facility-based exercise training program.
The program is facility based and supervised by a physiotherapist.
The program runs 3 times weekly for 12 weeks.
The exercise is group-based.
The exercise program lasts approximately 1 hour and consists of a brief warm-up phase (bicycle ergometer at moderate intensity) followed by a circuit training program focusing on strength and endurance exercises of the large muscle groups (e.g.
quadriceps).
Participants allocated to usual care will receive instructions related to healthy living, alcohol absenteeism, and benefits of increased physical activity.
The instructions will be provided by a physical therapist and/or a nurse, and will be given according to recommendations and local and national guidance.
The participants are offered continued regular visits at the rehabilitation clinic, but no supervised physical exercise.
|
Experimental: SMS-messages
12 weeks of supervised physical exercise followed by usual care in the outpatient liver cirrhosis rehabilitation clinic + regular text messages via SMS over a 12-week period
|
A 12 week supervised and facility-based exercise training program.
The program is facility based and supervised by a physiotherapist.
The program runs 3 times weekly for 12 weeks.
The exercise is group-based.
The exercise program lasts approximately 1 hour and consists of a brief warm-up phase (bicycle ergometer at moderate intensity) followed by a circuit training program focusing on strength and endurance exercises of the large muscle groups (e.g.
quadriceps).
Participants allocated to SMS-messages will receive the same intervention as usual care (see above) AND regular text messages via SMS over a 12-week period. The text messages will be unidirectional and will serve as motivational information but will not allow two-way communication with a researcher or health professional about clinical management. The messages will provide information, motivation, and support to adhere to a healthy lifestyle, alcohol absenteeism, and physical activity and will reinforce the information and instructions received at the face-to-face information (usual care). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in The Model for End-Stage Liver Disease (MELD) score
Time Frame: week -12, 0, 12, 24
|
The MELD is a reliable measure of mortality risk in patients with end-stage liver disease. The MELD is based on a mathematical equation. The MELD score is calculated using the following formula: MELD Score = 9.57 x ln (creatinine mg/dL) + 3.78 x ln(bilirubin mg/dL) + 11.2 x ln(INR)+ 6.43 |
week -12, 0, 12, 24
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
10.2.1.1 Child-Pugh score
Time Frame: week -12, 0, 12, 24
|
week -12, 0, 12, 24
|
|
Quality of life, SF-36v1
Time Frame: week -12, 0, 12, 24
|
10.2.2.1 Quality of life, SF-36v1 Short Form-36v1 is a standardised patient-reported instrument for use as a measure of health outcome and quality of life
|
week -12, 0, 12, 24
|
SOKRATES questionnaire
Time Frame: week -12, 0, 12, 24
|
SOKRATES8a is a standardised patient-reported instrument for use as a measure of readiness for change in alcohol abusers
|
week -12, 0, 12, 24
|
Sickness Impact Profile (SIP) questionnaire
Time Frame: week -12, 0, 12, 24
|
The Sickness Impact Profile (SIP) questionnaire is a 136 items generic health status measure
|
week -12, 0, 12, 24
|
Six-Minute Walk Test
Time Frame: week -12, 0, 12, 24
|
The Six-Minute Walk-Test (6MWT) assesses general physical function.
The test is performed in an undisturbed hospital corridor marked every 2 meters with coloured tape on the floor; starting and turning points marked by cones.
Subjects are instructed to walk as fast as they can.
They are allowed to stop or rest during the test if necessary and walking aids are allowed.
The distance in meters covered during the 6 minutes is the outcome of the test.
|
week -12, 0, 12, 24
|
30-seconds chair stand test
Time Frame: week -12, 0, 12, 24
|
The 30-seconds chair stand test (30-s CST) is performed in an undisturbed room with hands crossed against the chest.
It is one of the most important functional evaluation clinical tests because it measures lower body strength and relates it to the most demanding daily life activities.
A 30-s CST consists of standing up and sitting down from a chair as many times as possible within 30 seconds.
|
week -12, 0, 12, 24
|
Muscle Power
Time Frame: week -12, 0, 12, 24
|
The Leg Extensor Power Rig will be used to measure muscle power (force x velocity) in a non-invasive way.
The participants will be in a seated position and a single explosive limb extension will accelerate a flywheel from rest.
The participants will be instructed to kick the pedal as hard and fast as possible.
Repeated kicks are performed, until a significant decline in power is observed.
The kick with maximal power is the result of the text, and is recorded in Watts.
|
week -12, 0, 12, 24
|
Standard blood sample
Time Frame: week -12, 0, 12, 24
|
As part of the usual assessment of the patients, standard blood samples (15ml) are drawn and analysed (4 visits x 15 ml = 60 ml per participant).
The analyses include: Haemoglobin (Hgb), white blood cells, Bilirubin, ALAT, ASAT, INR, platelets, CRP, creatinine, urea, sodium, potassium, alkaline phosphatase albumin, coagulations factors II VII and X.
|
week -12, 0, 12, 24
|
Plasma concentrations of inflammatory markers
Time Frame: week -12, -6, 0
|
EDTA plasma will be collected at before and after 12 weeks of supervised training intervention, and before and after a single exercise session in week 6 to analyse specific for cytokines/myokines interactions e.g.
TNF alfa and IL-6.
|
week -12, -6, 0
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Continuous Reaction Time
Time Frame: week -12, 0, 12, 24
|
Continuous Reaction Time (CRT) is a 10-minute computer-based test measuring the patient's reaction-time to a beep-sound and the patient's ability to concentrate.
CRT-index below 1.9 is compatible with minimal hepatic encephalopathy .
|
week -12, 0, 12, 24
|
Portosystemic Encephalopathy test
Time Frame: week -12, 0, 12, 24
|
The Portosystemic Encephalopathy test (PSE) measures complex cognitive functions such as attention, accuracy, working speed, and visual orientation.
It is a paper-and-pencil test consisting of five subtests: Digit Symbol test, Number Connection Test A, Number Connection Test B, Serial Dotting Test, and Line Tracing Test.
Calculating the test score from the seconds spent on each subtest takes 5 minutes.
The summed test score, the portosystemic hepatic encephalopathy score (PHES), ranges from 218 to 6, and a result below 24 is abnormal.
|
week -12, 0, 12, 24
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Christian H Dall, PhD, Bispebjerg Frederiksberg Hospital
- Principal Investigator: Nanna M Jensen, PhD, Bispebjerg Frederiksberg Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FYS003
- H-16025360 (Other Identifier: The Committees on Health Research Ethics in the Capital Region of Denmark)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Cirrhosis, Alcoholic
-
Pharmicell Co., Ltd.RecruitingAlcoholic CirrhosisKorea, Republic of
-
University Hospital, MontpellierNarbonne Hospital; University Hospital, NîmesTerminatedAlcoholic Liver Disease | Alcoholic CirrhosisFrance
-
Assistance Publique - Hôpitaux de ParisCompletedAlcoholic Hepatitis | Alcoholic CirrhosisFrance
-
Pharmicell Co., Ltd.CompletedAlcoholic Liver CirrhosisKorea, Republic of
-
Stempeutics Research Pvt LtdCompletedAlcoholic Liver CirrhosisIndia
-
Yonsei UniversityUnknownAlcoholic Liver CirrhosisKorea, Republic of
-
Pharmicell Co., Ltd.UnknownAlcoholic Liver CirrhosisUnited States
-
Pharmicell Co., Ltd.CompletedAlcoholic Liver CirrhosisKorea, Republic of
-
Conatus Pharmaceuticals Inc.TerminatedLiver Diseases | Liver Cirrhosis | Liver Fibrosis | NASH Fibrosis | Decompensated Non-Alcoholic Steatohepatitis Cirrhosis | Orthotopic Liver TransplantationUnited States
-
Nantes University HospitalCompleted
Clinical Trials on Supervised exercise
-
University of ManchesterUnknownCardiovascular Diseases | Peripheral Arterial Disease
-
Hull University Teaching Hospitals NHS TrustCompletedAbdominal Aortic AneurysmUnited Kingdom
-
Universidad de AlmeriaCompletedLow Back Pain | Physical ActivitySpain
-
Medical University of ViennaUnknownPeripheral Artery DiseaseAustria
-
Hasselt UniversityRecruitingGestational Hypertension | Cardiovascular Pregnancy ComplicationBelgium
-
University Health Network, TorontoCompletedProstate CancerCanada
-
Grupo Rehabilitacion en SaludClinica Las AmericasCompletedChronic Heart FailureColombia
-
Ahram Canadian UniversityRecruiting
-
Northwestern Health Sciences UniversityHealth Resources and Services Administration (HRSA); Berman Center for Outcomes...Completed
-
Istanbul University - Cerrahpasa (IUC)RecruitingAmyotrophic Lateral SclerosisTurkey